INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 247
RESEARCH DOSSIER / NOT AN ENDORSEMENT

welludr (wellmedr.com)

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

Fast online weight, hormone and sexual-health positioning with licensed-clinician review and discreet delivery. Current catalog is narrower: GLP-1, NAD, B12 and Sermorelin consultations; old speed/approval/benefit claims are not independently verified.

Audienceread

Our read: cash-pay adults seeking low advertised GLP prices and online convenience; older copy targets men's sexual/hormone/hair concerns, but those services are currently coming soon. Eligibility/clinical approval, not advertising, determines treatment.

Pricing & termssnapshot

Advertised GLP floors: semaglutide $49/month, tirzepatide $89/month; NAD+/sermorelin from $99/month. Exact plan charge unverified; policy distinguishes 21-day renewals from prepaid terms.

Clinical relationshipsverified

Posted consent names OpenLoop Healthcare Partners, PC and state affiliates, including CA, CO, NJ and WI practices. WellMedr LLC provides nonclinical technology/admin support and does not practice medicine. Current named clinician/patient-state assignment not verified; consent is evidence of disclosed network, not audited contracts.

Pharmacy & fulfillmentverified

Current terms/service-availability page names Logos RX/Logos Pharmacy (Tampa), Emerald Compounding Pharmacy (Tampa) and Center City Pharmacy (West Palm Beach). Assignment varies by treatment, location and availability; physical compounder can differ from dispensing pharmacy and must be identified on prescription material. No guaranteed drug-level assignment inferred.

Advertising snapshotsnapshot

Google, Meta and LinkedIn public-library snapshots inspected 16 Oct2026. Counts, dates, attribution and copy limits are separated below.

Founding yearpartial

2025: BBB lists business start 29 May; Florida registry aggregator lists LLC formation 11 June. Business-start versus entity-registration dates differ; consumer brand launch not independently verified.

Foundersnot_found

No supported founder identified. BBB/registry aggregator list Emmanuel Carnero and Livcore Group LLC as managers, not founders. Welludr and WellMedr branding/legal spelling vary across pages.

Location & entity contextpartial

BBB lists 7901 4th St N Ste300, St Petersburg FL33702. Registry aggregator lists principal/mailing address 15475 SW16th Ln, Miami FL33185 and St Petersburg registered agent. These are legal/listing addresses, not independently verified clinical HQ.

Search visibility samplesnapshot

Public search returned official homepage plus treatment/terms pages on 16 Oct 2026. This establishes indexed presence only, not Google ranking, traffic, authority or acquisition performance.

THE MODERN DOSING WEEKLY

The peptide news
that changes your week.

Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.